Akutní lymfoblastická leukemie
- prof. MUDr. Michael Doubek, Ph.D., Interní hematologická a onkologická klinika FN Brno, Brno
- prof. MUDr. Jan Starý, DrSc., Klinika dětské hematologie a onkologie, FN v Motole, Praha
- MUDr. Jacqueline Maaloufová, Ústav hematologie a krevní transfuze, Praha
Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia
Otevřít | 2015 | MUDr. Štěpán Hrabovský
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission
Otevřít | 2010 | MUDr. Štěpán Hrabovský
T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)
Otevřít | 2009 | doc. MUDr. Michael Doubek, Ph.D.
Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols
Otevřít | 2008 | MUDr. František Folber
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol
Otevřít | 2008 | MUDr. František Folber
Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult pacients with high-risk acute lymphoblastic leukemia
Otevřít | 2008 | MUDr. František Folber
Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial
Otevřít | 2008 | MUDr. František Folber
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
Otevřít | 2008 | MUDr. František Folber
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
Otevřít | 2008 | MUDr. František Folber
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801
Otevřít | 2008 | MUDr. František Folber
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
Otevřít | 2008 | MUDr. František Folber
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Otevřít | 2008 | MUDr. Ladislav Król
Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group
Otevřít | 2008 | MUDr. Ladislav Król
High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia
Otevřít | 2008 | MUDr. Ladislav Król
Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first comlete remission: analysis of LALA-85, -87 and 94 trials
Otevřít | 2008 | MUDr. Markéta Protivánková
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancor annd Leukemia Group B Study 9511
Otevřít | 2008 | MUDr. Markéta Protivánková
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
Otevřít | 2008 | MUDr. Markéta Protivánková
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993
Otevřít | 2008 | MUDr. Markéta Protivánková
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patiens enrolled in the GIMEMA LAL 0496 protocol
Otevřít | 2008 | MUDr. Markéta Protivánková
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993
Otevřít | 2008 | MUDr. Markéta Protivánková
Allogeneic hematopoietic stem Cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia
Otevřít | 2008 | MUDr. Markéta Protivánková
High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL positive acute lymphoblastic leukemia: A phase II study by Japan Adult Leukemia Study Group
Otevřít | 2008 | MUDr. Markéta Protivánková
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission
Otevřít | 2008 | MUDr.František Folber
High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia
Otevřít | 2008 | Prof. MUDr. Jan Starý, DrSc.
Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study
Otevřít | 2007 | doc. MUDr. Michael Doubek, Ph.D.